Nascent BiotechNBIO
13F holders, Q1 2024 (March 31)1holders
$0.15avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Nascent Biotech Inc. (NBIO) in their 13F filings. The largest holder was Cubic Asset Management, LLC ($16K).
- Company
- Nascent Biotech Inc.
- CUSIP
- 63108Q101
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Cubic Asset Management, LLC | 0.00% | No change | 105,000 | $16K |
"% of holder's portfolio" is NBIO's weight in each manager's 13F, not the share of Nascent Biotech Inc. the manager owns.